Market Cap N/A
Revenue (ttm) 218.14M
Net Income (ttm) -89.98M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 20,000
Avg Vol 18,478
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 19%
Beta N/A
Analysts Strong Sell
Price Target N/A

Company Profile

Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care products to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and protect and enhance skin tone and texture; cosmetics; and other beauty products. In addition, the company provides foundation, concealer, primer,...

Phone: 44 20 3196 0264
Address:
81 Fulham Road, Suite 560, London, United Kingdom
Latest News on WALDW
Waldencast announces conclusion of SEC investigation

Apr 28, 2026, 6:12 PM EDT - 15 days ago

Waldencast announces conclusion of SEC investigation


Waldencast price target lowered to $2 from $4 at Canaccord

2026-03-16T10:42:44.000Z - 2 months ago

Waldencast price target lowered to $2 from $4 at Canaccord


Waldencast price target lowered to $2 from $4 at Canaccord

2026-03-13T19:00:39.000Z - 2 months ago

Waldencast price target lowered to $2 from $4 at Canaccord


Waldencast reports Q4 revenue $72M vs. $72.1M last year

2026-03-13T10:55:13.000Z - 2 months ago

Waldencast reports Q4 revenue $72M vs. $72.1M last year


Waldencast Reports Q4 2025 and FY 2025 Financial Results

Mar 13, 2026, 6:50 AM EDT - 2 months ago

Waldencast Reports Q4 2025 and FY 2025 Financial Results


Waldencast Transcript: AGM 2026

Jan 14, 2026, 12:00 PM EST - 4 months ago

Waldencast Transcript: AGM 2026


Waldencast assumed with a Buy at Jefferies

2026-01-14T11:31:33.000Z - 4 months ago

Waldencast assumed with a Buy at Jefferies


Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum

Oct 8, 2025, 8:00 AM EDT - 7 months ago

Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum


Waldencast Earnings Call Transcript: Q1 2025

May 14, 2025, 8:30 AM EDT - 1 year ago

Waldencast Earnings Call Transcript: Q1 2025


Waldencast Reports Q1 2025 Financial Results

May 13, 2025, 4:15 PM EDT - 1 year ago

Waldencast Reports Q1 2025 Financial Results


Waldencast Earnings Call Transcript: Q4 2024

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Waldencast Earnings Call Transcript: Q4 2024


Milk Makeup to Launch at Ulta Beauty This Spring

Jan 28, 2025, 6:45 AM EST - 1 year ago

Milk Makeup to Launch at Ulta Beauty This Spring


Waldencast Transcript: 27th Annual ICR Conference 2025

Jan 13, 2025, 9:30 AM EST - 1 year ago

Waldencast Transcript: 27th Annual ICR Conference 2025


Waldencast Earnings Call Transcript: Q3 2024

Nov 21, 2024, 8:30 AM EST - 1 year ago

Waldencast Earnings Call Transcript: Q3 2024


Waldencast Reports Q3 2024 Financial Results

Nov 20, 2024, 5:00 PM EST - 1 year ago

Waldencast Reports Q3 2024 Financial Results


Waldencast Earnings Call Transcript: Q2 2024

Aug 28, 2024, 8:30 AM EDT - 1 year ago

Waldencast Earnings Call Transcript: Q2 2024


Waldencast Reports Q2 2024 Financial Results

Aug 27, 2024, 5:26 PM EDT - 1 year ago

Waldencast Reports Q2 2024 Financial Results


Waldencast Earnings Call Transcript: Q1 2024

May 21, 2024, 8:30 AM EDT - 2 years ago

Waldencast Earnings Call Transcript: Q1 2024


Waldencast Reports Q1 2024 Financial Results

May 21, 2024, 6:45 AM EDT - 2 years ago

Waldencast Reports Q1 2024 Financial Results


Waldencast Reports Fiscal Year 2023 Financial Results

Apr 30, 2024, 6:45 AM EDT - 2 years ago

Waldencast Reports Fiscal Year 2023 Financial Results


Waldencast Regains Compliance with Nasdaq Filing Requirements

Mar 25, 2024, 5:05 PM EDT - 2 years ago

Waldencast Regains Compliance with Nasdaq Filing Requirements